Related Experiment Videos
H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium.
1Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel. tanosv@spidernet.com.cy
Summary
H19 gene expression is elevated in the epithelium of endometrial hyperplasia and cancer, suggesting its potential as a diagnostic and prognostic marker. Insulin-like growth factor 2 (IGF2) showed no diagnostic or prognostic value.
Area of Science:
- Gynecology
- Oncology
- Molecular Biology
Background:
- Endometrial cancer is a significant health concern.
- Identifying reliable biomarkers for diagnosis and prognosis is crucial.
- The role of H19 and insulin-like growth factor 2 (IGF2) in endometrial pathologies requires further elucidation.
Purpose of the Study:
- To investigate the expression patterns of H19 and IGF2 in normal endometrium, endometrial hyperplasia, and endometrial cancer.
- To assess the potential of H19 and IGF2 as diagnostic or prognostic markers in endometrial cancer.
Main Methods:
- Non-radioactive in situ hybridization was employed.
- Gene expression of H19 and IGF2 was analyzed in epithelial and stromal cells.
- Samples included normal endometrium (12), hyperplasia (27), and cancer (27) tissues.
Main Results:
- H19 was absent in normal endometrial epithelium but present in 15% of hyperplastic and 60% of cancerous epithelium.
- Epithelial H19 expression increased with decreasing tumor differentiation.
- Stromal H19 expression decreased from normal (75%) to hyperplasia (55%) and cancer (37%).
- IGF2 expression did not show significant diagnostic or prognostic utility.
Conclusions:
- H19 expression in endometrial epithelial cells is a promising biomarker for endometrial hyperplasia and cancer.
- H19 may serve as a complementary histopathologic and prognostic marker in endometrial cancer.
- IGF2 is not a useful marker for endometrial cancer diagnosis or prognosis.